Search Results 1-10 of 17001 for GLP-1 drug adjustments

  1. Prescription weight-loss drugs - Mayo Clinic

    FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety ...

  2. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... Drug Interactions. Although certain medicines ... Other medicines—Do not take other medicines ...

  3. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... Drug Interactions. Although certain medicines ... Your doctor may adjust your dose as needed.

  4. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    By condition, treatment or drug name. Search tips ... GLP1 Agonist and GLP-1/ GIP agonist medications. ... medication treatment to six months after in an ...

  5. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    By condition, treatment or drug name. Search tips. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent ...

  6. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists (GLP ... Drug Administration (FDA) warning against their ... 1 to 2 years or after two years of follow-up. This ...

  7. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... Drug Interactions. Although certain medicines ... Other medicines—Do not take other ...

  8. Preoperative Gastric Content With Ultrasound Assessment in Patients Taking GLP1 Agonists - Mayo Clinic

    By condition, treatment or drug name. Search tips ... glucagon-like peptide 1 (GLP-1) agonist ... GLP 1 patient group: any patient on GLP1 agonists ...

  9. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    ... medicines available to help control blood sugar ... A medication may work by: ... Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP ...

  10. Obesity - Diagnosis and treatment - Mayo Clinic

    Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. Some of these medicines are approved ...